Additionally, factors associated with cancer survival in this subgroup of patients were examined using univariate and multivariate analyses, which indicated that IgG-Fn status was a factor for predicting CSS outcome (positive vs. negative: HR 2.22, 95% CI 1.40–3.53; p < 0.001) (S1 Table). The gene discussed is FN1; the disease is cancer.